 |
PDBsum entry 1x8t
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Interaction of phosphonate analogues of the tetrahedral reaction intermediate with 5-Enolpyruvylshikimate-3-Phosphate synthase in atomic detail.
|
 |
|
Authors
|
 |
M.A.Priestman,
M.L.Healy,
A.Becker,
D.G.Alberg,
P.A.Bartlett,
G.H.Lushington,
E.Schönbrunn.
|
 |
|
Ref.
|
 |
Biochemistry, 2005,
44,
3241-3248.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
The enzyme 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) catalyzes the
penultimate step of the shikimate pathway and is the target of the
broad-spectrum herbicide glyphosate. Since the functionality of the shikimate
pathway is vital not only for plants but also for microorganisms, EPSPS is
considered a prospective target for the development of novel antibiotics. We
have kinetically analyzed and determined the crystal structures of Escherichia
coli EPSPS inhibited by (R)- and (S)-configured phosphonate analogues of the
tetrahedral reaction intermediate. Both diastereomers are competitive inhibitors
with respect to the substrates of the EPSPS reaction, shikimate-3-phosphate
(S3P) and phosphoenolpyruvate (PEP). Remarkably, the (S)-phosphonate (K(iS3P) =
750 nM), whose configuration corresponds to that of the genuine tetrahedral
intermediate, is a much weaker inhibitor than the (R)-phosphonate analogue
(K(iS3P) = 16 nM). The crystal structures of EPSPS liganded with the (S)- and
(R)-phosphonates, at 1.5 and 1.9 A resolution, respectively, revealed that
binding of the (R)-phosphonate induces conformational changes of the strictly
conserved residues Arg124 and Glu341 within the active site. This appears to
give rise to substantial structural alterations in the amino-terminal globular
domain of the enzyme. By contrast, binding of the (S)-phosphonate renders the
enzyme structure unchanged. Thus, EPSPS may facilitate the tight binding of
structurally diverse ligands through conformational flexibility. Molecular
docking calculations did not explain why the (R)-phosphonate is the better
inhibitor. Therefore, we propose that the structural events during the
open-closed transition of EPSPS are altered as a result of inhibitor action.
|
 |
|
|
|
|
 |